Lymph node threshold in colorectal cancer: surgeons' perspectives and practices.
Nandan Padmanabha1,2, Yevgen Chornenkyy3, Wenyu Pan4
1Pathology, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA.
Surgeon views on low lymph node (LN) counts in colorectal cancer surgery vary, with many believing it rarely impacts treatment despite potential links to poorer outcomes. Clear communication between surgeons and pathologists is key for patient care.
Area of Science:
- Oncology
- Surgical Pathology
Background:
- Current guidelines recommend examining at least 12 lymph nodes (LN) in colorectal cancer resections.
- Suboptimal lymph node yield is a concern in surgical pathology.
Purpose of the Study:
- To survey surgeon perspectives on suboptimal lymph node yield (<12).
- To assess interpretive variability and beliefs regarding the clinical impact of low lymph node yield.
Main Methods:
- A voluntary 19-question electronic survey was distributed to colorectal and general surgeons.
- The survey explored clinical, pathological, and molecular considerations in cases with low lymph node yield.
Main Results:
- 71% of 168 respondents reported infrequent suboptimal lymph node yields, while 29% encountered them regularly.
- Opinions diverged on managing low lymph node yield, especially when N-stage was achieved or considering fat submission.
- 49% believed low lymph node yield rarely alters treatment, though many acknowledged its association with poorer outcomes. Neoadjuvant therapy and specimen characteristics were cited as contributing factors.
Conclusions:
- Surgeon perspectives on the significance and causes of suboptimal lymph node yield vary, despite the '12-node rule'.
- Effective communication between surgeons and pathologists is crucial for understanding factors influencing lymph node yield and optimizing patient care.
More Related Videos
08:26Clinical Application of Single-Surgeon, Three-Port, Laparoscopic Resection for Colorectal Cancer with Natural Orifice Specimen Extraction
Published on: March 24, 2023
12:45Robot-assisted Total Mesorectal Excision and Lateral Pelvic Lymph Node Dissection for Locally Advanced Middle-low Rectal Cancer
Published on: February 12, 2022
